BioNano Genomics Inc (BNGO)
NASDAQ:BNGO

BioNano Genomics (BNGO) Financial Statements

8,843 Followers

BioNano Genomics Financial Overview

BioNano Genomics's market cap is currently ―. The company's EPS TTM is $-6.006; its P/E ratio is -0.11; BioNano Genomics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 10.72M$ 9.32M$ 8.66M$ 7.42M$ 8.21M
Gross Profit$ 2.44M$ 2.75M$ 2.31M$ 2.07M$ 1.80M
EBIT$ -39.03M$ -112.46M$ -38.80M$ -37.02M$ -37.57M
EBITDA$ -35.38M$ -108.86M$ -35.60M$ -33.86M$ -34.75M
Net Income Common Stockholders$ -43.89M$ -112.57M$ -38.91M$ -37.12M$ -38.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 66.70M$ 63.60M$ 77.10M$ 95.80M$ 113.20M
Total Assets$ 214.40M$ 181.90M$ 271.42M$ 292.15M$ 307.50M
Total Debt$ 79.41M$ 10.14M$ 10.66M$ 11.17M$ 11.67M
Net Debt$ 12.71M$ -53.46M$ -66.44M$ -84.63M$ -101.53M
Total Liabilities$ 118.25M$ 62.91M$ 56.63M$ 60.66M$ 58.10M
Stockholders Equity$ 96.16M$ 119.00M$ 214.71M$ 231.49M$ 249.40M
Cash Flow-
Free Cash Flow$ -31.49M$ -24.04M$ -35.93M$ -32.40M$ -34.73M
Operating Cash Flow$ -29.80M$ -24.07M$ -35.90M$ -32.40M$ -34.52M
Investing Cash Flow$ -55.37M$ 31.21M$ 28.79M$ 16.53M$ 11.61M
Financing Cash Flow$ 68.48M$ 12.59M$ 17.88M$ 14.86M$ 146.00K
Currency in USD

BioNano Genomics Earnings and Revenue History

BioNano Genomics Debt to Assets

BioNano Genomics Cash Flow

BioNano Genomics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis